Авторы

  • A.M. Umarkhodjaev
    Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan Tashkent Medical Academy, Tashkent, Uzbekistan
  • S.S. Gulyamov
    Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan Tashkent Medical Academy, Tashkent, Uzbekistan
  • R.R. Sadykov
    Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan Tashkent Medical Academy, Tashkent, Uzbekistan

DOI:

https://doi.org/10.71337/inlibrary.uz.zdtf.84874

Аннотация

Post-burn scars remain one of the most difficult challenges in reconstructive and aesthetic dermatology. They often lead to physical discomfort, psychological distress, and social adaptation difficulties, especially when localized on visible parts of the body. Standard treatment methods may not always be effective due to the individual characteristics of scar tissue formation, healing dynamics, and skin type. An individualized approach using combined laser and photodynamic therapy (PDT) presents a promising alternative. This dual-modality strategy enhances treatment efficiency through synergistic effects of laser ablation and cellular-level photochemical reactions induced by photosensitizers. Such an approach aims to optimize treatment outcomes and minimize side effects.


background image

129

INDIVIDUALIZED LASER-PHOTODYNAMIC THERAPY IN THE TREATMENT

OF POST-BURN SCARS

Umarkhodjaev A.M.

Gulyamov S.S.

Sadykov R.R.

Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

Tashkent Medical Academy, Tashkent, Uzbekistan

https://doi.org/10.5281/zenodo.15350243

Relevance

Post-burn scars remain one of the most difficult challenges in reconstructive and

aesthetic dermatology. They often lead to physical discomfort, psychological distress, and
social adaptation difficulties, especially when localized on visible parts of the div. Standard
treatment methods may not always be effective due to the individual characteristics of scar
tissue formation, healing dynamics, and skin type. An individualized approach using combined
laser and photodynamic therapy (PDT) presents a promising alternative. This dual-modality
strategy enhances treatment efficiency through synergistic effects of laser ablation and
cellular-level photochemical reactions induced by photosensitizers. Such an approach aims to
optimize treatment outcomes and minimize side effects.

Objective:

To evaluate the clinical efficacy and safety of individualized laser-

photodynamic therapy in the management of post-burn scars.

Materials and Methods:

The clinical study included 28 patients aged 7 to 45 years with

post-burn scars located on the face, neck, and upper limbs. Patients were individually
assessed using ultrasonography and scar classification scales to determine the treatment
protocol. Laser therapy was performed using fractional CO2 and pulsed dye lasers.
Photodynamic therapy was administered with second-generation photosensitizers and 635
nm light source. Each patient underwent 3–5 treatment sessions with a 2-week interval. The
efficacy was evaluated based on the Vancouver Scar Scale, patient satisfaction surveys, and
photographic documentation.

Results:

Clinical results showed significant improvements in scar texture, color, and

flexibility in 85% of cases. On the Vancouver Scar Scale, average scores improved from 10.4 to
5.1. Patients reported a reduction in itching and tightness and improved cosmetic appearance.
No serious adverse effects were observed, and mild erythema resolved within 48 hours. The
individualized approach allowed for the customization of laser parameters and PDT dosing,
improving therapeutic precision.

Conclusion:

Individualized laser-photodynamic therapy is an effective and safe method

for treating post-burn scars. The personalized approach allows for optimized treatment
protocols tailored to the patient's scar characteristics, resulting in improved clinical outcomes
and higher patient satisfaction. This technique should be considered a valuable addition to
modern scar management practices.

References:

Используемая литература:

Foydalanilgan adabiyotlar:

1.

Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ.

Trends in Endocrinology &


background image

130

Metabolism.

2000;11(8):327–332.

2.

Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ.

Journal of Clinical

Endocrinology & Metabolism.

2004;89(6):2548–2556.

3.

Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic

disease.

Nature Reviews Immunology.

2011;11(2):85–97.

4.

Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation

and immunity.

Nature Reviews Immunology.

2006;6(10):772–783.

5.

Steppan C.M., Lazar M.A. The current biology of resistin.

Journal of Internal Medicine.

2004;255(4):439–447.
6.

Fasshauer M., Blüher M. Adipokines in health and disease.

Trends in Pharmacological

Sciences.

2015;36(7):461–470.

7.

Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications.

Diabetologia.

2012;55(9):2319–2326.

Библиографические ссылки

Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends in Endocrinology & Metabolism. 2000;11(8):327–332.

Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2548–2556.

Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology. 2011;11(2):85–97.

Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology. 2006;6(10):772–783.

Steppan C.M., Lazar M.A. The current biology of resistin. Journal of Internal Medicine. 2004;255(4):439–447.

Fasshauer M., Blüher M. Adipokines in health and disease. Trends in Pharmacological Sciences. 2015;36(7):461–470.

Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319–2326.